Latest Articles
GSK Advances New Maintenance Therapy Trial in Endometrial Cancer, Adding Depth to Its Oncology Pipeline - TipRanks
GSK Advances New Maintenance Therapy Trial in Endometrial Cancer, Adding Depth to Its Oncology Pipeline TipRanks
Published: July 15, 2026, 4:46 p.m.
Matilda Djerf Says It Took Her ‘Months’ to Feel Like Herself Again After Ectopic Pregnancy - AOL.com
Matilda Djerf Says It Took Her ‘Months’ to Feel Like Herself Again After Ectopic Pregnancy AOL.com
Published: July 15, 2026, 4:37 p.m.
US Says Ceasefire Is Holding Despite Iran's Attacks In The Strait Of Hormuz And Against The UAE Endometriosis (t3A5vggIfI) - Mshale
US Says Ceasefire Is Holding Despite Iran's Attacks In The Strait Of Hormuz And Against The UAE Endometriosis (t3A5vggIfI) Mshale
Published: July 15, 2026, 4:26 p.m.
Two tests GPs can soon offer to help spot endometriosis - AOL.com
Two tests GPs can soon offer to help spot endometriosis AOL.com
Published: July 15, 2026, 4:06 p.m.
Rethinking Endometriosis: A Whole-Body Disease - Yale Medicine
Rethinking Endometriosis: A Whole-Body Disease Yale Medicine
Published: July 15, 2026, 4:01 p.m.
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer - OncLive
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer OncLive
Published: July 15, 2026, 3:58 p.m.
TV star says doctors ‘nicked’ vital artery during routine procedure: ‘Lucky to be alive’ - Cleveland.com
TV star says doctors ‘nicked’ vital artery during routine procedure: ‘Lucky to be alive’ Cleveland.com
Published: July 15, 2026, 3:58 p.m.
TV star says doctors ‘nicked’ vital artery during routine procedure: ‘Lucky to be alive’ - OregonLive.com
TV star says doctors ‘nicked’ vital artery during routine procedure: ‘Lucky to be alive’ OregonLive.com
Published: July 15, 2026, 3:58 p.m.
Barbara Palvin Got Real About Spiraling Over Pregnancy Weight Gain - AOL.com
Barbara Palvin Got Real About Spiraling Over Pregnancy Weight Gain AOL.com
Published: July 15, 2026, 3:14 p.m.
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy - BioSpace
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy BioSpace
Published: July 15, 2026, 3:11 p.m.
Link copied to clipboard!